Get started
Author

Thomas Grace

Observed names: THOMAS GRACE, Thomas P. Grace
ORCID: 0009-0002-0168-4005
Observed ORCID: 0009-0002-0168-4005
OpenAlex ID: A5039507028
Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy
2021 · Thomas Grace, Jay Salyer · Diabetes Technology & Therapeutics · 67
AMCP Market Insights Health Plan Best Practice: Implementing continuous glucose monitoring to improve patient outcomes in diabetes
2024 · Michael Pangrace, Sheri Dolan, et al. · Journal of Managed Care & Specialty Pharmacy · 9
PDF
The Dexcom Community Glucose Monitoring Project: 6-Month Results Using Continuous Glucose Monitoring in Type 2 Diabetes
2024 · Thomas P. Grace, Andrew Edgington, et al. · Clinical Diabetes · 6
PDF
Continuous glucose monitoring guides glucagon-like peptide 1-based therapy use and optimization in people with type 2 diabetes
2025 · Rita Parsiani, Thomas Grace, et al. · Journal of Family Medicine and Primary Care · 5
982-P: The Dexcom Community Glucose Monitoring Project for People with Type 2 Diabetes—One-Year Outcomes
2024 · THOMAS GRACE, JENNIFER E. LAYNE, et al. · Diabetes · 1
How CGM Use in Adults With Type 2 Diabetes Leads to Glycemic Benefits: The Role of Medication and Behaviour Change
2026 · William H. Polonsky, Taylor L. Clark, et al. · Endocrinology Diabetes & Metabolism
600-P: Real-Time CGM Coverage Eligibility Should Include Type 2 Diabetes Patients Treated with Less-Intensive Therapy
2021 · THOMAS GRACE, JAY SALYER · Diabetes
Works count: 7
Citation count: 88
H-index: 4
I10-index: 1
Year
Topic
Type